Content posted against Serum Institute of India prima facie defamatory: HC

Monday, 5 June 2023
The SII filed a defamation suit in December 2022 seeking damages to the tune of Rs 100 crore from the two individuals and their organisations for allegedly posting erroneous content against the company and its COVID-19 vaccine Covishield

👓 View full article

0 shares	Share Tweet Save Post Send

Content posted against Serum Institute of India, its Covishield vaccine prima facie defamatory: Bombay HC

The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII)...
IndiaTimes on June 5, 2023

Bombay HC says content posted against Covishield vaccine prima facie defamatory

The Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII)...
Mid-Day on June 5, 2023

Content posted against Serum Institute of India prima facie defamatory: HC

You Might Like

Related news from verified sources

Content posted against Serum Institute of India, its Covishield vaccine prima facie defamatory: Bombay HC

Bombay HC says content posted against Covishield vaccine prima facie defamatory